Nordic American Life Science Conference 2022

THE 7th ANNUAL NORDIC AMERICAN LIFE SCIENCE CONFERENCE, NEW YORK CITY

Celebrating Nordic American Life Science Investment and Partnering - Open to qualified investors and biopharma, medtech, healthtech developers

• The most comprehensive gathering of Nordic life science innovation in the US, covering key company developments and trends from Norway, Sweden, Denmark, Finland and Iceland

• The only event of its kind in the US, providing the largest US-Nordic forum for life sciences; an intimate and highly curated gathering

• Taking place over two days in New York City, the conference brings together leading Nordic biotechnology, medtech and healthtech companies with investors for networking with industry partners, innovation organizations and corporate development

• Hosted by DNB, Nasdaq, Business Sweden and Innovation Norway, with Back Bay Life Science Advisors founded on the goal of fostering ongoing US-Nordic collaboration, investment and driving Nordic life science development forward

• Presentations by leading Nordic biopharma, medtech and healthtech companies in areas with high patient need including oncology, cardiovascular, metabolic health, wound care and vaccines

Expert panel discussions and workshops covering industry trends and challenges, including:

• Business challenges in new technologies (CAR T, microbiome, mRNA)
• Critical issues in digital healthcare development
• Impact of current public markets on life science deals
• Nordic equity valuations
• Alternative financing and partnering trends

To learn more or to become involved with The Nordic American Life Science Conference, please reach out. We look forward to hearing from you!

VIEW PROGRAM AND VIDEOS: https://www.nordic-americanlifescience.com

This event is open to qualified investors and active biopharma, medtech and healthtech developers. Event organizers reserve the right to cancel bookings.